title: The effects of FSH and activin A on follicle development in vitro.
abstract: Numerous studies have reported on the roles of activins in gonadal regulation; however, little is known about their specific roles in early folliculogenesis. Ovarian follicular growth was investigated in 10-day cultures of day 4 postnatal whole ovaries treated with activin A (ActA; 50 ng/ml), with or without FSH (100 ng/ml) in vitro. We hypothesized that treatment with ActA±FSH would affect rates of growth and atresia in follicles. None of the treatments affected primordial follicle activation, and antral follicles were not observed after 10 days in culture. Primordial follicle numbers from all treatment groups were ∼20% of those in day 4 fresh ovaries, indicating that activation had occurred. In the presence of ActA, preantral follicle numbers increased significantly (P<0.0001). ActA alone decreased the proportion of atretic follicles in the primary and preantral classes, whereas the combined treatment of ActA+FSH increased the proportion of atretic preantral oocytes. Real-time PCR analysis revealed that follistatin, FSH receptor, and activin βA and βB subunits were all expressed at significantly higher levels in the ActA-only treated group but not in the ActA+FSH group. Here, we report novel findings supporting the role of FSH in primordial follicle survival through an action on apoptosis and a stimulatory role of ActA in the primordial to primary and preantral stages of follicle development, suggesting an inhibitory action of activin on oocyte apoptosis.
authors: Prince Henry's Institute of Medical Research, Clayton, Victoria, Australia.
authors: Davina A
authors: DA
authors: Cossigny
authors: Jock K
authors: JK
authors: Findlay
authors: Ann E
authors: AE
authors: Drummond
mesh_terms: D028341:Activins / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology* / Q000502:physiology; D000818:Animals; D017209:Apoptosis / Q000187:drug effects / Q000235:genetics; D002470:Cell Survival / Q000187:drug effects / Q000235:genetics; D002478:Cells, Cultured; D005260:Female; D005640:Follicle Stimulating Hormone / Q000235:genetics / Q000378:metabolism / Q000494:pharmacology* / Q000502:physiology; D038681:Follistatin / Q000235:genetics / Q000494:pharmacology; D005786:Gene Expression Regulation / Q000187:drug effects; D009865:Oocytes / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D006080:Ovarian Follicle / Q000187:drug effects* / Q000378:metabolism / Q000502:physiology; D012333:RNA, Messenger / Q000235:genetics; D051381:Rats; D017207:Rats, Sprague-Dawley; D011962:Receptors, FSH / Q000235:genetics / Q000378:metabolism
chemical_list: D038681:Follistatin; D012333:RNA, Messenger; D011962:Receptors, FSH; C422405:activin A; D028341:Activins; D005640:Follicle Stimulating Hormone